# Augmenting Atropine Treatment for Amblyopia in Children 3 to < 8 Years Old

> **NCT00944710** · PHASE3 · COMPLETED · sponsor: **Jaeb Center for Health Research** · enrollment: 73 (actual)

## Conditions studied

- Amblyopia

## Interventions

- **DRUG:** Atropine
- **DEVICE:** Plano lens
- **DRUG:** Atropine

## Key facts

- **NCT ID:** NCT00944710
- **Lead sponsor:** Jaeb Center for Health Research
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2013-10
- **Final completion:** 2013-11
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2019-03-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00944710

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00944710, "Augmenting Atropine Treatment for Amblyopia in Children 3 to < 8 Years Old". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00944710. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*